LGND Competitors & Alternatives
Compare Ligand Pharmaceuticals Incorporated with similar stocks in the same industry
Biotechnology
LGND
Main Stock$279.44
Tradestie Score
64
Market Cap
$3.49B
P/E Ratio
34.1
Revenue Growth
0.1%
Analyst Upside
-0.2%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRSP
CRISPR Therapeutics AG
|
$53.99
|
$6.02B | - | 59 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.44
|
$5.95B | - | 60 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$241.97
|
$5.92B | - | 59 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$53.94
|
$5.80B | 19.0 | 57 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$340.21
|
$5.20B | 46.2 | 60 | Compare |
|
ALKS
Alkermes Inc. plc
|
$48.07
|
$5.06B | 51.1 | 65 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$51.96
|
$4.94B | - | 60 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$82.13
|
$4.93B | - | 56 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$79.90
|
$4.84B | - | 62 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
More LGND Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry